FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/09/2026
Back to search
Official data from USPTO
IONCTURA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
07/09/2026
Trademark type
Word
Nice classes
5, 41
Filing date
02/20/2025
Registration date
12/09/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/09/2025
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
CH
Examiner
O'BRIEN, JENNIFER LYNN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
iOnctura SA
Representatives
Shoko Naruo Thompson Coburn LLP
Technical classification
Nice Classes
Class 5Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of cancer; anti-fibrotic pharmaceutical preparations; anti-inflammatory pharmaceutical preparations; chemical preparations for medical and pharmaceutical purposes for cancer; anti-fibrotic chemical preparations for medical and pharmaceutical purposes; anti-inflammatory chemical preparations for medical and pharmaceutical purposes; pharmaceutical preparations for use in oncology; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceutical preparations for the treatment of cancer; Organic compounds being a component in pharmaceutical preparations for treating cancer; anti-cancer preparations; anti-cancer drugs being anti-cancer preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disordersimmunomodulators
Class 41
Education servicesconducting of classesseminarsconferences and workshops in the field of pharmaceuticals; Training services in the field of pharmaceuticals; arranging and conducting of seminars in the field of oncology; arranging and conducting seminars in the field of cancer; arranging and conducting seminars in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/24/2026
FIMP
FINAL DISPOSITION PROCESSED
06/24/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/09/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/09/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/21/2025
PUBO
PUBLISHED FOR OPPOSITION
10/21/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/15/2025
RFNT
REFUSAL PROCESSED BY IB
09/27/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/23/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/23/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/09/2025
RFRR
REFUSAL PROCESSED BY MPU
09/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/01/2025
CNRT
NON-FINAL ACTION WRITTEN
07/31/2025
DOCK
ASSIGNED TO EXAMINER
07/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/25/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/25/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/17/2025
Continuous trademark protection
Get notified about every new filing that threatens IONCTURA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.